Delivery Order SPE2DB24D2215-SPE2DB25FGTFB
Award Date 8/11/25
Potential Completion Date 8/12/25
Potential Value $11K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $5,755.68 to AmerisourceBergen Drug Corp for ACTEMRA ACTPEN 162 MG/0.9 ML auto-injectors. This non-set-aside, firm fixed price delivery order was awarded on July 22, 2025, with an ultimate completion date of July 23, 2025. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ACTEMRA (tocilizumab) is a biologic immunosuppressant used to treat rheumatoid arthritis and other...
- The Defense Logistics Agency awarded a delivery order valued at $38,677.92 to AmerisourceBergen Drug Corp for Actemra ActPen 162 mg/0.9 mL auto-injectors. This firm fixed-price delivery order, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a non-competitive award under the company's existing indefinite delivery contract with DLA. The pharmaceutical product will be delivered to AmerisourceBergen's corporate headquarters location in Conshohocken,...
- The Defense Logistics Agency awarded a $5,755.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Actemra Actpen 162 mg/0.9 mL auto-injector pens. This is a non-set-aside, competitively awarded contract with performance completion targeted for August 12, 2025, with fulfillment occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a child contract under AmerisourceBergen's broader...
- The U.S. Department of Defense Medical Supply Chain awarded a $6,235.68 delivery order to AmerisourceBergen Drug Corp for Actemra ActPen 162 mg/0.9 ml auto-injectors. This firm fixed-price, non-set-aside contract was executed on August 11, 2025, with an ultimate completion date of August 12, 2025. The award represents a child delivery order under AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a $8,021.19 delivery order to AmerisourceBergen Drug Corp for ACTEMRA ACTPEN 162 MG/0.9 ML pharmaceutical product, with a completion date of July 23, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and will be performed in Conshohocken, Pennsylvania. The delivery order represents a single transaction under AmerisourceBergen's broader federal pharmaceutical supply portfolio supporting military and veteran healthcare...
- The Defense Logistics Agency awarded a delivery order valued at $32,838.00 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL auto-injector pens. The contract, executed on July 28, 2025, with an ultimate completion date of July 29, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $18,202.15 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL auto-injectors. This firm fixed price delivery order, awarded on August 4, 2025, with an ultimate completion date of August 5, 2025, represents a competitive award with no set-aside designation. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, supporting the company's role as a...
- The Defense Logistics Agency awarded a $48,698.09 delivery order to AmerisourceBergen Drug Corp for Actemra Actpen 162 mg/0.9 mL pharmaceutical supplies. This firm fixed price, competitively awarded contract was executed on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,058.52 to AmerisourceBergen Drug Corp for the supply of Actemra ActPen 162 mg/0.9 mL injectable medication. Issued on August 14, 2025, with an ultimate completion date of August 15, 2025, this firm fixed-price contract requires performance at the company's Conshohocken, Pennsylvania location. The award was competitively awarded with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet...
- The U.S. Defense Logistics Agency (DLA) awarded a $11,769.62 delivery order to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. Under this IDC, Amerisourcebergen provides a comprehensive range of pharmaceutical products and medical...